INSP
Price
$158.42
Change
+$10.05 (+6.77%)
Updated
Apr 24, 04:59 PM (EDT)
Capitalization
6.35B
11 days until earnings call
MASI
Price
$162.55
Change
+$4.62 (+2.93%)
Updated
Apr 24, 04:59 PM (EDT)
Capitalization
7.66B
19 days until earnings call
Ad is loading...

INSP vs MASI

Header iconINSP vs MASI Comparison
Open Charts INSP vs MASIBanner chart's image
Inspire Medical Systems
Price$158.42
Change+$10.05 (+6.77%)
Volume$4.16K
Capitalization6.35B
Masimo
Price$162.55
Change+$4.62 (+2.93%)
Volume$21.53K
Capitalization7.66B
INSP vs MASI Comparison Chart
Loading...
INSP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MASI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
INSP vs. MASI commentary
Apr 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is INSP is a StrongBuy and MASI is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Apr 25, 2025
Stock price -- (INSP: $148.37 vs. MASI: $157.76)
Brand notoriety: INSP and MASI are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: INSP: 77% vs. MASI: 72%
Market capitalization -- INSP: $6.35B vs. MASI: $7.66B
INSP [@Medical Specialties] is valued at $6.35B. MASI’s [@Medical Specialties] market capitalization is $7.66B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.31B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

INSP’s FA Score shows that 0 FA rating(s) are green whileMASI’s FA Score has 1 green FA rating(s).

  • INSP’s FA Score: 0 green, 5 red.
  • MASI’s FA Score: 1 green, 4 red.
According to our system of comparison, MASI is a better buy in the long-term than INSP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

INSP’s TA Score shows that 6 TA indicator(s) are bullish while MASI’s TA Score has 6 bullish TA indicator(s).

  • INSP’s TA Score: 6 bullish, 3 bearish.
  • MASI’s TA Score: 6 bullish, 2 bearish.
According to our system of comparison, MASI is a better buy in the short-term than INSP.

Price Growth

INSP (@Medical Specialties) experienced а +0.99% price change this week, while MASI (@Medical Specialties) price change was +4.01% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +4.26%. For the same industry, the average monthly price growth was -6.64%, and the average quarterly price growth was -2.53%.

Reported Earning Dates

INSP is expected to report earnings on Aug 05, 2025.

MASI is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Medical Specialties (+4.26% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MASI($7.66B) has a higher market cap than INSP($6.35B). MASI YTD gains are higher at: -4.561 vs. INSP (-19.964). MASI has higher annual earnings (EBITDA): 237M vs. INSP (-17.06M). INSP has more cash in the bank: 460M vs. MASI (163M). INSP has less debt than MASI: INSP (24.8M) vs MASI (970M). MASI has higher revenues than INSP: MASI (2.05B) vs INSP (625M).
INSPMASIINSP / MASI
Capitalization6.35B7.66B83%
EBITDA-17.06M237M-7%
Gain YTD-19.964-4.561438%
P/E RatioN/A95.93-
Revenue625M2.05B31%
Total Cash460M163M282%
Total Debt24.8M970M3%
FUNDAMENTALS RATINGS
INSP vs MASI: Fundamental Ratings
INSP
MASI
OUTLOOK RATING
1..100
1972
VALUATION
overvalued / fair valued / undervalued
1..100
80
Overvalued
90
Overvalued
PROFIT vs RISK RATING
1..100
61100
SMR RATING
1..100
7593
PRICE GROWTH RATING
1..100
8156
P/E GROWTH RATING
1..100
10013
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

INSP's Valuation (80) in the Medical Specialties industry is in the same range as MASI (90). This means that INSP’s stock grew similarly to MASI’s over the last 12 months.

INSP's Profit vs Risk Rating (61) in the Medical Specialties industry is somewhat better than the same rating for MASI (100). This means that INSP’s stock grew somewhat faster than MASI’s over the last 12 months.

INSP's SMR Rating (75) in the Medical Specialties industry is in the same range as MASI (93). This means that INSP’s stock grew similarly to MASI’s over the last 12 months.

MASI's Price Growth Rating (56) in the Medical Specialties industry is in the same range as INSP (81). This means that MASI’s stock grew similarly to INSP’s over the last 12 months.

MASI's P/E Growth Rating (13) in the Medical Specialties industry is significantly better than the same rating for INSP (100). This means that MASI’s stock grew significantly faster than INSP’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
INSPMASI
RSI
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 2 days ago
67%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
73%
Momentum
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
81%
MACD
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
80%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
71%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
76%
Advances
ODDS (%)
Bullish Trend 8 days ago
87%
Bullish Trend 23 days ago
72%
Declines
ODDS (%)
Bearish Trend 21 days ago
72%
Bearish Trend 9 days ago
65%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
71%
Aroon
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
73%
View a ticker or compare two or three
Ad is loading...
INSP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MASI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
BUFG23.130.25
+1.09%
FT Vest Buffered Allocation Gr ETF
PRF38.300.40
+1.06%
Invesco RAFI US 1000 ETF
FLEE31.360.22
+0.72%
Franklin FTSE Europe ETF
BHV10.260.05
+0.49%
BlackRock Virginia Muni
XBIL50.140.01
+0.02%
US Treasury 6 Month Bill ETF

INSP and

Correlation & Price change

A.I.dvisor indicates that over the last year, INSP has been loosely correlated with TMCI. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if INSP jumps, then TMCI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INSP
1D Price
Change %
INSP100%
-0.23%
TMCI - INSP
54%
Loosely correlated
+2.40%
MASI - INSP
50%
Loosely correlated
+5.71%
NVRO - INSP
46%
Loosely correlated
N/A
SMLR - INSP
36%
Loosely correlated
+3.00%
VCYT - INSP
32%
Poorly correlated
+1.08%
More

MASI and

Correlation & Price change

A.I.dvisor indicates that over the last year, MASI has been loosely correlated with INSP. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if MASI jumps, then INSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MASI
1D Price
Change %
MASI100%
+5.71%
INSP - MASI
50%
Loosely correlated
-0.23%
HBIO - MASI
45%
Loosely correlated
+0.97%
VCYT - MASI
41%
Loosely correlated
+1.08%
PODD - MASI
40%
Loosely correlated
+0.95%
MMSI - MASI
39%
Loosely correlated
+2.47%
More